A Case-Control Study to Assess Procalcitonin Serum Levels in Children Under the Age of Five with UTI

Aim: The aim of the present study to evaluate the Procalcitonin Serum Levels in Children Younger than Five Years Old with Urinary Tract Infection. Methods: This case-control was done the Department of Paediatrics, Government Medical College, Bettiah, West Champaran, Bihar, India for 1 year. The 100 (100 case and 100 control) children less than 5 years of age were included in this study. The children in the case group suffered from UTI based on a positive urinary culture test. They also were undergone VCUG and accordingly were divided into two groups: having VUR and not having VUR. Their serum levels of PCT were measured before starting antibiotic therapy using the chemiluminiscence immunoassay (CLIA). They had negative results for both urine culture (UTI) and urinary analysis tests that the serum levels of PCT were measured for them. In both groups children under 5 years without genetically diseases and chronic kidney diseases included in the study. Results: Of the samples, 130 children (65%) were female. The median age of the samples was 23.7 months with an interquartile range between 11.5 and 36.5 months. Accordingly, both the evaluation methods diagnosed 90 children to be healthy, while 92% of children with VUR positive simultaneously were PCT positive. The odds of one positive and two positive for one way 1.714 (P=0.015) times and 1.212(P=0.785) times were higher than the group without reflux. However the odds of 4 positive for one way 0.239 (P=0.3) times was lower than control group. The positive and negative predictive values of the serum level of PCT were 40% and 90%, respectively. In this respect, 50% of the samples diagnosed by serum level of PCT were false positive and 12% were false negative. It meant that sensitivity and specificity of PCT measurement were 90% and 50%, respectively. The kappa score for the level of serum PCT was 0.5 (P < 0.0001). The positive predictive value of serum PCT for the female and male samples was 42% and 54% respectively. Conclusion: No statistically significant relationship between vesicoureteral reflux and the serum level of PCT.

[1]  T. Waterfield,et al.  Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study , 2018, BMC Pediatrics.

[2]  A. Van den Bruel,et al.  Point-of-care C reactive protein to identify serious infection in acutely ill children presenting to hospital: prospective cohort study , 2017, Archives of Disease in Childhood.

[3]  E. Chiappini,et al.  Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and meta-analysis , 2017, Expert review of anti-infective therapy.

[4]  P. Póvoa,et al.  Use of biomarkers in pediatric sepsis: literature review , 2016, Revista Brasileira de terapia intensiva.

[5]  A. Gervaix,et al.  Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants , 2016, Pediatrics.

[6]  S. Aronoff,et al.  Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients. , 2014, The Journal of emergency medicine.

[7]  H. Otukesh,et al.  Serum procalcitonin level for prediction of high-grade vesicoureteral reflux in urinary tract infection. , 2014, Iranian journal of kidney diseases.

[8]  P. Mahajan,et al.  Evaluation of child with fever without source: review of literature and update. , 2013, Pediatric clinics of North America.

[9]  K. Lue,et al.  Role of Procalcitonin in Predicting Dilating Vesicoureteral Reflux in Young Children Hospitalized With a First Febrile Urinary Tract Infection , 2013, The Pediatric infectious disease journal.

[10]  Chien-Chang Lee,et al.  Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. , 2012, Annals of emergency medicine.

[11]  G. Breart,et al.  Prediction of High-Grade Vesicoureteral Reflux after Pediatric Urinary Tract Infection: External Validation Study of Procalcitonin-Based Decision Rule , 2011, PloS one.

[12]  K. Lue,et al.  The role of procalcitonin for acute pyelonephritis and subsequent renal scarring in infants and young children. , 2011, The Journal of urology.

[13]  A. Gervaix,et al.  Procalcitonin: A Key Marker in Children with Urinary Tract Infection , 2011, Advances in urology.

[14]  Frank Buntinx,et al.  Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review , 2010, The Lancet.

[15]  D. Gendrel,et al.  [Procalcitonin and prediction of vesico-ureteral reflux in pediatric urinary tract infection]. , 2007, Bulletin de l'Académie Nationale de Médecine.

[16]  G. Breart,et al.  Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection. , 2006, Pediatrics.

[17]  C. Byington,et al.  Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. , 2004, Pediatrics.

[18]  J. Šimák,et al.  [Procalcitonin--a marker of systemic infection and multiorgan dysfunction: characteristics of the gene and protein]. , 2001, Ceskoslovenska fysiologie.

[19]  J. Bouyer,et al.  Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants. , 2016, JAMA pediatrics.

[20]  A. Ghafari,et al.  Diagnostic Values of Serum Procalcitonin in Kidney Diseases , 2015 .

[21]  J. Judge FEVER IN THE PEDIATRIC PATIENT. , 1965, The Journal of the American Osteopathic Association.